These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8532911)

  • 1. Quality assurance of the EORTC radiotherapy trial 22863 for prostatic cancer: the dummy run.
    Dusserre A; Garavaglia G; Giraud JY; Bolla M
    Radiother Oncol; 1995 Sep; 36(3):229-34. PubMed ID: 8532911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality assurance of the EORTC trial 22911. A phase III study of post-operative external radiotherapy in pathological stage T3N0 prostatic carcinoma: the dummy run.
    Davis JB; Reiner B; Dusserre A; Giraud JY; Bolla M;
    Radiother Oncol; 2002 Jul; 64(1):65-73. PubMed ID: 12208577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality assurance of the 22961 EORTC trial. A phase III study of the optimal combination of hormonal adjuvant treatment by LHRH analogue and radiation therapy for the management of locally advanced prostate cancer: the dummy run.
    Kouloulias VE; Giraud JY; Davis BJ; Dusserre A; Zurlo A; Bolla M
    Radiother Oncol; 2004 Oct; 73(1):11-20. PubMed ID: 15465141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality assurance of the EORTC 22043-30041 trial in post-operative radiotherapy in prostate cancer: results of the Dummy Run procedure.
    Fenton PA; Hurkmans C; Gulyban A; van der Leer J; Matzinger O; Poortmans P; Collette L; Bolla M
    Radiother Oncol; 2013 Jun; 107(3):346-51. PubMed ID: 23707151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality assurance of the EORTC radiotherapy trial 22931 for head and neck carcinomas: the dummy run.
    Valley JF; Bernier J; Tercier PA; Fogliata-Cozzi A; Rosset A; Garavaglia G; Mirimanoff RO
    Radiother Oncol; 1998 Apr; 47(1):37-44. PubMed ID: 9632290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review.
    Matzinger O; Poortmans P; Giraud JY; Maingon P; Budiharto T; van den Bergh AC; Davis JB; Musat E; Ataman F; Huyskens DP; Gulyban A; Bolla M;
    Radiother Oncol; 2009 Mar; 90(3):285-90. PubMed ID: 19038468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality assurance of the EORTC 26981/22981; NCIC CE3 intergroup trial on radiotherapy with or without temozolomide for newly-diagnosed glioblastoma multiforme: the individual case review.
    Ataman F; Poortmans P; Stupp R; Fisher B; Mirimanoff RO
    Eur J Cancer; 2004 Jul; 40(11):1724-30. PubMed ID: 15251162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality assurance in preoperative radiotherapy of rectal cancer: evaluation of a pre-trial dummy-run.
    Widder J; Sedlmayer F; Stanek C; Pötter R
    Radiother Oncol; 2000 Sep; 56(3):341-7. PubMed ID: 10974384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality assurance of axillary radiotherapy in the EORTC AMAROS trial 10981/22023: the dummy run.
    Hurkmans CW; Borger JH; Rutgers EJ; van Tienhoven G; ;
    Radiother Oncol; 2003 Sep; 68(3):233-40. PubMed ID: 13129630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A glance on quality assurance in EORTC study 22922 evaluating techniques for internal mammary and medial supraclavicular lymph node chain irradiation in breast cancer.
    Lievens Y; Poortmans P; Van den Bogaert W
    Radiother Oncol; 2001 Sep; 60(3):257-65. PubMed ID: 11514005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High conformality radiotherapy in Europe: thirty-one centres participating in the quality assurance programme of the EORTC prostate trial 22991.
    Ataman F; Poortmans P; Davis JB; Bernier J; Giraud JY; Kouloulias VE; Pierart M; Bolla M
    Eur J Cancer; 2004 Nov; 40(16):2411-6. PubMed ID: 15519513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10.
    Sassowsky M; Gut P; Hölscher T; Hildebrandt G; Müller AC; Najafi Y; Kohler G; Kranzbühler H; Guckenberger M; Zwahlen DR; Azinwi NC; Plasswilm L; Takacs I; Reuter C; Sumila M; Manser P; Ost P; Böhmer D; Pilop C; Aebersold DM; Ghadjar P
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):534-41. PubMed ID: 23972722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The need for immediate monitoring of treatment parameters and uniform assessment of patient data in clinical trials. A quality control study of the EORTC Radiotherapy and Lung Cancer Cooperative Groups.
    Schaake-Koning C; Kirkpatrick A; Kröger R; van Zandwijk N; Bartelink H
    Eur J Cancer; 1991; 27(5):615-9. PubMed ID: 1647185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing Radiation Therapy Quality Assurance in Clinical Trials: A TROG 08.03 RAVES Substudy.
    Trada Y; Kneebone A; Paneghel A; Pearse M; Sidhom M; Tang C; Wiltshire K; Haworth A; Fraser-Browne C; Martin J
    Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1045-51. PubMed ID: 26475066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy for Prostate Cancer: is it 'what you do' or 'the way that you do it'? A UK Perspective on Technique and Quality Assurance.
    Mason MD; Moore R; Jones G; Lewis G; Donovan JL; Neal DE; Hamdy FC; Lane JA; Staffurth JN;
    Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):e92-e100. PubMed ID: 27425582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality assurance in the CHART clinical trial.
    Aird EG; Williams C; Mott GT; Dische S; Saunders MI
    Radiother Oncol; 1995 Sep; 36(3):235-44. PubMed ID: 8532912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality assurance in MR image guided adaptive brachytherapy for cervical cancer: Final results of the EMBRACE study dummy run.
    Kirisits C; Federico M; Nkiwane K; Fidarova E; Jürgenliemk-Schulz I; de Leeuw A; Lindegaard J; Pötter R; Tanderup K
    Radiother Oncol; 2015 Dec; 117(3):548-54. PubMed ID: 26316396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global harmonization of quality assurance naming conventions in radiation therapy clinical trials.
    Melidis C; Bosch WR; Izewska J; Fidarova E; Zubizarreta E; Ulin K; Ishikura S; Followill D; Galvin J; Haworth A; Besuijen D; Clark CH; Miles E; Aird E; Weber DC; Hurkmans CW; Verellen D
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1242-9. PubMed ID: 25539374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial experience with quality assurance of multi-institutional 3D radiotherapy clinical trials. A brief report.
    Purdy JA; Harms WB; Michalski J; Bosch WR
    Strahlenther Onkol; 1998 Oct; 174 Suppl 2():40-2. PubMed ID: 9810337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality improvements in prostate radiotherapy: outcomes and impact of comprehensive quality assurance during the TROG 03.04 'RADAR' trial.
    Kearvell R; Haworth A; Ebert MA; Murray J; Hooton B; Richardson S; Joseph DJ; Lamb D; Spry NA; Duchesne G; Denham JW
    J Med Imaging Radiat Oncol; 2013 Apr; 57(2):247-57. PubMed ID: 23551788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.